Archive - February 2018
UK Bioindustry Association Launches Genomics Advisory Committee
Greek lawmakers launch probe into 10 officials accused of taking Novartis bribes
Novo Nordisk trumpets first phase 3 oral semaglutide results. Does Lilly need to worry yet?
Recipharm reports 2017 sales growth but expansion hit bottom line hard
Modern Healthcare staffers named finalists for Jesse H. Neal Awards
Industry urges CMS to continue ACA wraparound coverage option
Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble
Regeneron vision drug Eylea sees upward tick in unexplained side-effect cases